160 results on '"Le-Petross, Huong T"'
Search Results
2. Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy: ECOG-ACRIN EA1211/DIRECT trial.
3. ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update
4. Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection
5. Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer
6. ACR Appropriateness Criteria® Imaging of the Axilla
7. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density
8. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
9. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women
10. Robotic DIEP Patient Selection: Analysis of CT Angiography
11. ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer
12. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer
13. Screening Modalities for Women at Intermediate and High Risk for Breast Cancer
14. Effect of Mammography on Marker Clip Migration After Stereotactic-Guided Core Needle Breast Biopsy
15. Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance
16. Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).
17. Abstract P3-02-03: Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients
18. Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review
19. Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer
20. Imaging Updates to Breast Cancer Lymph Node Management
21. Inflammatory breast cancer appearance at presentation is associated with overall survival
22. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer
23. The need for MRI before breast-conserving surgery
24. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
25. Abstract PD6-06: Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients
26. Abstract PD6-07: Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients
27. Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges
28. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial
29. Unknown Primary Presenting with Axillary Lymphadenopathy
30. Contributors
31. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer
32. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
33. Breast density, MR imaging biomarkers, and breast cancer risk
34. Application of Three-Dimensional Printed Vascular Modeling as a Perioperative Guide to Perforator Mapping and Pedicle Dissection during Abdominal Flap Harvest for Breast Reconstruction
35. Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
36. ACR Appropriateness Criteria® Evaluation of the Symptomatic Male Breast
37. ACR Appropriateness Criteria® Breast Pain
38. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.
39. Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): Results of CALGB (Alliance) 70806.
40. Role of MR Imaging in Neoadjuvant Therapy Monitoring
41. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
42. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
43. Mammographic breast density is associated with the development of contralateral breast cancer.
44. ACR Appropriateness Criteria® Breast Pain.
45. ACR Appropriateness Criteria® Evaluation of the Symptomatic Male Breast.
46. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy
47. Association between tumor stage of first non-metastatic breast cancer and second contralateral breast cancer.
48. From the lab to the clinic: Lessons learned from a translational working group.
49. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
50. chapter 85 - Unknown Primary Presenting with Axillary Lymphadenopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.